229 related articles for article (PubMed ID: 31932072)
41. Stat3 contributes to indoxyl sulfate-induced inflammatory and fibrotic gene expression and cellular senescence.
Shimizu H; Yisireyili M; Nishijima F; Niwa T
Am J Nephrol; 2012; 36(2):184-9. PubMed ID: 22889746
[TBL] [Abstract][Full Text] [Related]
42. The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.
Shivanna S; Kolandaivelu K; Shashar M; Belghasim M; Al-Rabadi L; Balcells M; Zhang A; Weinberg J; Francis J; Pollastri MP; Edelman ER; Sherr DH; Chitalia VC
J Am Soc Nephrol; 2016 Jan; 27(1):189-201. PubMed ID: 26019318
[TBL] [Abstract][Full Text] [Related]
43. Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
Assefa EG; Yan Q; Gezahegn SB; Salissou MTM; He S; Wu N; Zuo X; Ying C
Oxid Med Cell Longev; 2019; 2019():5847040. PubMed ID: 31885805
[TBL] [Abstract][Full Text] [Related]
44. Indoxyl Sulfate, a Uremic Endotheliotoxin.
Lano G; Burtey S; Sallée M
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
[TBL] [Abstract][Full Text] [Related]
45. Indoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells.
Ng HY; Yisireyili M; Saito S; Lee CT; Adelibieke Y; Nishijima F; Niwa T
PLoS One; 2014; 9(3):e91517. PubMed ID: 24614509
[TBL] [Abstract][Full Text] [Related]
46. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
[TBL] [Abstract][Full Text] [Related]
47. Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.
Wakamatsu T; Yamamoto S; Ito T; Sato Y; Matsuo K; Takahashi Y; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29543732
[TBL] [Abstract][Full Text] [Related]
48. Indoxyl sulfate in uremia: an old idea with updated concepts.
Berg AH; Kumar S; Karumanchi SA
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981787
[TBL] [Abstract][Full Text] [Related]
49. TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.
Lu CL; Liao CH; Lu KC; Ma MC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867359
[TBL] [Abstract][Full Text] [Related]
50. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
Bobot M
Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
[TBL] [Abstract][Full Text] [Related]
51. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
52. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys.
Miyazaki T; Ise M; Seo H; Niwa T
Kidney Int Suppl; 1997 Nov; 62():S15-22. PubMed ID: 9350672
[TBL] [Abstract][Full Text] [Related]
53. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
54. Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice.
Yabuuchi N; Hou H; Gunda N; Narita Y; Jono H; Saito H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578912
[TBL] [Abstract][Full Text] [Related]
55. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
Niwa T; Ise M
J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
[TBL] [Abstract][Full Text] [Related]
56. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin.
Zhang Y; Wang S; Huang Y; Yang K; Liu Y; Bi X; Liu C; Xiong J; Zhang B; Zhao J; Nie L
Mol Med Rep; 2020 Jan; 21(1):393-404. PubMed ID: 31746392
[TBL] [Abstract][Full Text] [Related]
58. Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization.
Hung SC; Kuo KL; Huang HL; Lin CC; Tsai TH; Wang CH; Chen JW; Lin SJ; Huang PH; Tarng DC
Kidney Int; 2016 Mar; 89(3):574-85. PubMed ID: 26880454
[TBL] [Abstract][Full Text] [Related]
59. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
60. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
